Interferon beta-1b treatment in patients with relapsing-remitting multiple sclerosis under a standardized protocol in spain

Acta Neurologica Scandinavica

Volumn 102, Issue 4, 2000, Pages 209-217

  Arbizu, T ^a,i   Alvarez Cermeno J C ^b   Decap, G ^c   Fernandez O ^d   Uria D F ^e   Garcia Merino A ^f   Izquierdo, G ^g   Montalban X ^h  

^a Hospital de Belivitge   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c Vitatron Medical España   (Spain)

^d Hospital Carlos Haya   (Spain)

^e HOSPITAL SAN AGUSTÍN   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ Hospital de Belivitge   (Spain)

Author keywords

Interferon beta 1b; Multiple sclerosis; Spain

Indexed keywords

INTERFERON BETA SERINE;

ADULT; ARTICLE; CLINICAL PROTOCOL; DISABILITY; DRUG EFFICACY; ERYTHEMA; FEMALE; FLU LIKE SYNDROME; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RECURRENT DISEASE; SKIN DEFECT; SPAIN; THROMBOCYTOPENIA;

ADJUVANTS, IMMUNOLOGIC; ADULT; CATCHMENT AREA (HEALTH); CLINICAL PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SPAIN; TREATMENT OUTCOME;

EID: 0033802664     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102004209.x     Document Type: Article

References (16)

1. Genes and susceptibility to multiple sclerosis
2. Multiple sclerosis: Changing times
3. Multiple Sclerosis in Southern Europe I: Prevalence in Sicily in 1975
4. The prevalence of multiple sclerosis in the Sanitary District of Velez-Malaga, southern Spain
5. Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain
6. Multiple sclerosis in Gijon health district, Asturias, northern Spain
7. Multiple sclerosis in Mostoles, central Spain
8. Multiple sclerosis in Italy and in southern Europe
9. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis
10. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
11. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
12. Randomized double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis
13. A purchaser perspective of managing new drugs: Interferon beta as a case study
14. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
15. Rating neurological impairment in multiple sclerosis: An expanded disability scale (EDSS)
16. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomised controlled trial